Gillison Maura L, Chaturvedi Anil K, Anderson William F, Fakhry Carole
Maura L. Gillison, The Ohio State University Wexner Medical Center, Columbus, OH; Anil K. Chaturvedi and William F. Anderson, National Cancer Institute, National Institutes of Health, Rockville; and Carole Fakhry, Johns Hopkins Hospital, Baltimore, MD.
J Clin Oncol. 2015 Oct 10;33(29):3235-42. doi: 10.1200/JCO.2015.61.6995. Epub 2015 Sep 8.
Human papillomavirus (HPV) is now established as the principal cause of an increase in incidence of a subset of head and neck squamous cell cancers (HNCs) in numerous geographic regions around the world. Further study of the epidemiology of HPV-positive HNC will be critical to the development and implementation of public health interventions to reverse these global incidence trends. Here, recent data are reviewed to provide insight into several topics, including incidence trends and projections for HPV-positive HNC; the worldwide HPV-attributable fraction; sex disparities in cancer risk; the epidemiology of oral HPV infection; the latency period between infection and cancer; the potential impact of prophylactic HPV vaccination; and prospects for secondary prevention through screening for oral HPV infection or seroreactivity to viral antigens. The identification of a single necessary cause for any cancer provides a rare and perhaps extraordinary opportunity for cancer prevention.
人乳头瘤病毒(HPV)现已被确认为全球众多地理区域中一部分头颈鳞状细胞癌(HNC)发病率上升的主要原因。进一步研究HPV阳性HNC的流行病学对于制定和实施公共卫生干预措施以扭转这些全球发病率趋势至关重要。在此,对近期数据进行综述,以深入了解几个主题,包括HPV阳性HNC的发病率趋势和预测;全球HPV归因比例;癌症风险的性别差异;口腔HPV感染的流行病学;感染与癌症之间的潜伏期;预防性HPV疫苗接种的潜在影响;以及通过筛查口腔HPV感染或对病毒抗原的血清反应性进行二级预防的前景。确定任何癌症的单一必要病因,为癌症预防提供了一个罕见且或许非同寻常的机会。